<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Specialized Health Services</title>
	<atom:link href="http://www.stockbloghub.com/category/specialized-health-services/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 16 May 2012 17:53:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(DVA) DaVita Incorporated &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2012/01/25/dva-davita-incorporated-bull-of-the-day/90800</link>
		<comments>http://www.stockbloghub.com/2012/01/25/dva-davita-incorporated-bull-of-the-day/90800#comments</comments>
		<pubDate>Wed, 25 Jan 2012 18:01:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=90800</guid>
		<description><![CDATA[We are upgrading our recommendation on DaVita, Inc. (DVA) to Outperform based on the company&#8217;s strong cash flows and strategic acquisitions. The new bundled ESRD payment system is also expected to be a long-term positive. The company&#8217;s third-quarter earnings slightly exceeded the Zacks Consensus Estimate on the back of strong top-line growth, partially offset by higher operating expenses. Moreover, a strong cash position expands the potential for meaningful M&#38;A. While the acquisition of DSI should bring in new opportunities in most states, the company has to divest some of its centers as a condition. Nevertheless, we believe downside from current levels is likely limited. Our six-month target price of $96.00 equates to 19.0x our earnings estimate for 2011. This price target implies an expected total return of 20.3% over that ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/25/dva-davita-incorporated-bull-of-the-day/90800/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Analyst Rating Steady at Neutral</title>
		<link>http://www.stockbloghub.com/2011/12/09/dva-davita-analyst-rating-steady-at-neutral/88267</link>
		<comments>http://www.stockbloghub.com/2011/12/09/dva-davita-analyst-rating-steady-at-neutral/88267#comments</comments>
		<pubDate>Fri, 09 Dec 2011 17:42:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DSI]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Gentiva Health Services Inc.]]></category>
		<category><![CDATA[GTIV]]></category>
		<category><![CDATA[HEALTHSOUTH Corporation]]></category>
		<category><![CDATA[HLS]]></category>
		<category><![CDATA[iShares KLD 400 Social Index]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88267</guid>
		<description><![CDATA[We have reiterated our Neutral recommendation on DaVita Inc. (DVA) based on strong top-line growth in the third quarter of 2011, which was partially offset by higher operating expenses. The company reported third-quarter operating earnings of $1.45 per share, exceeding the Zacks Consensus Estimate by a penny as well as $1.15 per share earned in the comparable quarter of 2010. DaVita has been generating strong operating cash flow, which increased at a 4-year CAGR (2007–2010) of 13.1%. Higher-than-expected cash flow during the first three quarters of 2011 also allowed the company to raise the 2011 operating cash flow guidance to $1.02–1.10 billion from $900–980 million. Additionally, DaVita has been following the strategy of growth through acquisitions. Acquisition of dialysis centers and businesses that own and operate dialysis centers, as well ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/09/dva-davita-analyst-rating-steady-at-neutral/88267/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic&#8217;s Third Quarter Mixed &#8211; View Lowered</title>
		<link>http://www.stockbloghub.com/2011/11/04/hgr-hanger-orthopedics-third-quarter-mixed-view-lowered/86151</link>
		<comments>http://www.stockbloghub.com/2011/11/04/hgr-hanger-orthopedics-third-quarter-mixed-view-lowered/86151#comments</comments>
		<pubDate>Fri, 04 Nov 2011 18:40:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86151</guid>
		<description><![CDATA[Orthotic and prosthetic (O&#38;P) company Hanger Orthopedic’s (HGR) third-quarter fiscal 2011 adjusted earnings of 46 cents a share beat the Zacks Consensus Estimate by a penny and surpassed the year-ago adjusted earnings of 37 cents. The adjusted earnings exclude the costs associated with acquisitions and the relocation of the company’s corporate headquarters from Bethesda, Maryland, to Austin, Texas. Profit (as reported) more than doubled year over year to $15.4 million (or 45 cents a share), powered by a double-digit expansion in sales. The year ago quarter’s profit was hit by a hefty (roughly $8 million) relocation charge. Hanger recorded modest relocation expenses in the third quarter. Revenues &#38; Margins Net sales surged 13.8% year over year to $235.3 million, just missing the Zacks Consensus Estimate of $236 million. Revenue growth ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/04/hgr-hanger-orthopedics-third-quarter-mixed-view-lowered/86151/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HWAY) Gallup-Healthways Report Well-Being</title>
		<link>http://www.stockbloghub.com/2011/09/20/hway-gallup-healthways-report-well-being/83153</link>
		<comments>http://www.stockbloghub.com/2011/09/20/hway-gallup-healthways-report-well-being/83153#comments</comments>
		<pubDate>Tue, 20 Sep 2011 19:18:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Healthways Inc]]></category>
		<category><![CDATA[HWAY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83153</guid>
		<description><![CDATA[Healthways (HWAY), the well-being enhancement company, and statistical research services provider Gallup recently announced the results of the monthly Gallup-Healthways Well-Being Index (“WBI”) for August 2011. The overarching WBI measure remained on the higher side at 66.1. The results in August marked for the first time that obesity scores, on a year-over-year basis, have dropped since the metric was introduced in 2008. The obesity measurement stood at 25.9% in August, thereby demonstrating a gradual decline in national obesity with the passage of 2011. Among the WBI sub-components, the Work Environment Index, which has not surpassed 49 since September 2009, continued to languish at 47.1. This was its third-lowest performance since the launch of the WBI. The Life Evaluation Index declined to 47.6 in the reported month, its worst performance since ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/20/hway-gallup-healthways-report-well-being/83153/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) BioScrip Analyst Maintains Neutral Rating on Shares</title>
		<link>http://www.stockbloghub.com/2011/08/16/bios-bioscrip-analyst-maintains-neutral-rating-on-shares/81415</link>
		<comments>http://www.stockbloghub.com/2011/08/16/bios-bioscrip-analyst-maintains-neutral-rating-on-shares/81415#comments</comments>
		<pubDate>Tue, 16 Aug 2011 16:57:27 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[AmerisourceBergen Corporation]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[Chico's FAS Inc.]]></category>
		<category><![CDATA[CHS]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=81415</guid>
		<description><![CDATA[We maintain our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $6.25. BioScrip reported a loss of 4 cents per share in the second quarter of fiscal 2011 compared with the year-ago quarter EPS of 6 cents. However, after deducting the impact of restructuring charges and legal settlement cost, adjusted EPS came in at 10 cents during the quarter, surpassing the Zacks Consensus Estimate of 6 cents. After a few disappointing quarters, impacted by pricing concessions on various specialty drugs, reimbursement pressures, the new industry-wide AWP standard and the overall impact of the weak economic environment, BioScrip is gradually witnessing improvement in its top line. During the second quarter, the company witnessed an 8.7% year-over-year upsidein revenues from its pharmacy services segment, partly offset by the existing ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/16/bios-bioscrip-analyst-maintains-neutral-rating-on-shares/81415/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FMS) Fresenius Medical Care Completes IDC Buy</title>
		<link>http://www.stockbloghub.com/2011/07/05/fms-fresenius-medical-care-completes-idc-buy/78359</link>
		<comments>http://www.stockbloghub.com/2011/07/05/fms-fresenius-medical-care-completes-idc-buy/78359#comments</comments>
		<pubDate>Wed, 06 Jul 2011 00:12:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[FMS]]></category>
		<category><![CDATA[FRESENIUS MED ADS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78359</guid>
		<description><![CDATA[Fresenius Medical Care (FMS), the largest provider of dialysis products and services on the planet, has wrapped up its acquisition of Euromedic International’s (“Euromedic”) dialysis service division International Dialysis Centers (“IDC”) for €485 million (roughly $648 million). This follows the regulatory approvals of the deal (announced in January 2011) by the anti-trust authorities. IDC provides treatment to over 8,200 hemodialysis patients mainly in Central and Eastern Europe and runs 70 clinics in nine nations. The acquisition enables Fresenius to expand its role in the dialysis care business, mainly in the fast-growing Eastern European markets, where IDC has a major presence. For its part, Euromedic will focus on cancer treatment and diagnostic arenas. The newly acquired business is expectedto contribute about $180 million in annual revenues for Fresenius. Moreover, the acquisition ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/05/fms-fresenius-medical-care-completes-idc-buy/78359/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FMS) Fresenius Medical Care Offers Tips for Summer</title>
		<link>http://www.stockbloghub.com/2011/07/01/fms-fresenius-medical-care-offers-tips-for-summer/78213</link>
		<comments>http://www.stockbloghub.com/2011/07/01/fms-fresenius-medical-care-offers-tips-for-summer/78213#comments</comments>
		<pubDate>Fri, 01 Jul 2011 20:36:11 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[FMS]]></category>
		<category><![CDATA[FRESENIUS MED ADS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78213</guid>
		<description><![CDATA[Fresenius Medical Care (FMS), the largest provider of dialysis products and services in the globe, recently offered advice to renal patients to monitor their fluid intake during the parched summer months. Further, the company offered tips to dialysis patients on how to satisfy their thirst, without risking their well-being, during this period. Dialysis is a life-preserving mechanism that purifies the blood of waste substances and regulates the physical chemistry when an individual’s kidneys fail. Dialysis patients usually need treatment on a regular basis unless they are recipients of a kidney transplant. Fresenius Medical Care North America (“FMCNA”) observes that most people increase their fluid intake in order to stay hydrated in summer. However, excessive intake of liquids can lead to a serious life threatening situation for dialysis patients. The kidneys ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/01/fms-fresenius-medical-care-offers-tips-for-summer/78213/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Adopts NextGen Healthcare Solutions</title>
		<link>http://www.stockbloghub.com/2011/06/16/hgr-hanger-orthopedic-adopts-nextgen-healthcare-solutions/76599</link>
		<comments>http://www.stockbloghub.com/2011/06/16/hgr-hanger-orthopedic-adopts-nextgen-healthcare-solutions/76599#comments</comments>
		<pubDate>Thu, 16 Jun 2011 21:57:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76599</guid>
		<description><![CDATA[Leading orthotic and prosthetic (O&#38;P) company Hanger Orthopedic (HGR) has partnered with NextGen Healthcare, the wholly-owned subsidiary of Quality Systems’ (QSII). Under the collaboration, Hanger will implement NextGen’s Ambulatory electronic health record (“EHR”) and Practice Management solutions to automate clinical and operational workflows (such as medical records, billing and scheduling) across hundreds of patient care centers. NextGen’s integrated Ambulatory Practice Management and EHR products enable coordination of patient care with formalized clinical and administrative workflows in any health care facility. Moreover, the company’s in-patient products such as NextGen Financials and NextGen Clinicals have extended its services to community and rural hospitals. Hanger leads in the O&#38;P patient care services market, operating through more than 675 patient care centers across the U.S. The company is enjoying healthy demand for its services. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/16/hgr-hanger-orthopedic-adopts-nextgen-healthcare-solutions/76599/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HWAY) Healthways Announces Insurance Deal for Wisconsin Fitness Drive</title>
		<link>http://www.stockbloghub.com/2011/06/16/hway-healthways-announces-insurance-deal-for-wisconsin-fitness-drive/76488</link>
		<comments>http://www.stockbloghub.com/2011/06/16/hway-healthways-announces-insurance-deal-for-wisconsin-fitness-drive/76488#comments</comments>
		<pubDate>Thu, 16 Jun 2011 14:24:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Healthways Inc]]></category>
		<category><![CDATA[HWAY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76488</guid>
		<description><![CDATA[Healthways (HWAY), the well-being enhancement company, recently announced a new agreement with WPS Health Insurance (a non-profit health insurer in Wisconsin), whereby over 38,000 Wisconsin residents will gain access to the well-known SilverSneakers Fitness Program. As of the beginning of June 2011, SilverSneakers became accessible to eligible enrollees of WPS Medicare Companion, a Medicare supplemental insurance program in the state. The SilverSneakers program is America’s foremost exercise and social support program that aims at keeping senior citizens fit. Its regimen was created keeping in mind the physical constraints of older citizens and training is accordingly imparted by certified trainers. WPS will offer SilverSneakers at no extra cost to its Medicare Companion enrollees. SilverSneakers grants eligible participants access to over 11,000 wellness and fitness clinics across the nation. Many centers provide ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/16/hway-healthways-announces-insurance-deal-for-wisconsin-fitness-drive/76488/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Analyst Maintains Outperform on Shares</title>
		<link>http://www.stockbloghub.com/2011/06/05/hgr-hanger-orthopedic-analyst-maintains-outperform-on-shares/74198</link>
		<comments>http://www.stockbloghub.com/2011/06/05/hgr-hanger-orthopedic-analyst-maintains-outperform-on-shares/74198#comments</comments>
		<pubDate>Mon, 06 Jun 2011 04:11:14 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=74198</guid>
		<description><![CDATA[We reaffirm our Outperform rating on orthotic and prosthetic (O&#38;P) company Hanger Orthopedic (HGR)  as we remain upbeat about its business prospects. Earnings for first-quarter fiscal 2011 matched the Zacks Consensus Estimate while profit skyrocketed 55% year over year owing to the combined impact of higher revenues and management’s cost containment initiatives. Healthy contributions from the company’s therapeutic solutions and distribution businesses coupled with the acquisition of rehabilitation technologies provider Accelerated Care Plus (“ACP”) fueled double-digit growth in the top line. However, sales missed the Zacks Consensus Estimate. Hanger’s patient care business was negatively impacted by inclement weather. The company raised its earnings forecast for fiscal 2011 while maintaining its sales expectation for the year. Moreover, it remains optimistic about the growth prospects in its patient care business for the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/05/hgr-hanger-orthopedic-analyst-maintains-outperform-on-shares/74198/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Beats Earnings Estimates on Revenues</title>
		<link>http://www.stockbloghub.com/2011/05/04/dva-davita-beats-earnings-estimates-on-revenues/73182</link>
		<comments>http://www.stockbloghub.com/2011/05/04/dva-davita-beats-earnings-estimates-on-revenues/73182#comments</comments>
		<pubDate>Wed, 04 May 2011 16:48:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Credit Suisse Group]]></category>
		<category><![CDATA[CS]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73182</guid>
		<description><![CDATA[DaVita Inc. (DVA) reported first-quarter net operating income of $94.5 million, or 96 cents per share, exceeding the Zacks Consensus Estimate by a penny. However, DaVita lagged the earnings of $109.4 million or $1.04 per share in the comparable quarter of 2010. This was attributable to better-than-expected revenues and strong cash flows of the company. However, higher operating expenses resulted in the decline. Net operating revenues for the reported quarter climbed 3.0% year-over-year to $1.61 billion, beating the Zacks Consensus Estimate of $1.60 billion. Total operating expenses and charges for the quarter climbed 4.3% year-over-year to $1.37 billion. DaVita’s quarterly consolidated operating income, including stock based compensation and equity investment income plummeted approximately 2.9% year-over-year to $236 million. Operating income margin for the reported quarter stood at 14.7% as opposed ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/04/dva-davita-beats-earnings-estimates-on-revenues/73182/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) BioScrip Pharmacy Accredited</title>
		<link>http://www.stockbloghub.com/2011/04/12/bios-bioscrip-pharmacy-accredited/71235</link>
		<comments>http://www.stockbloghub.com/2011/04/12/bios-bioscrip-pharmacy-accredited/71235#comments</comments>
		<pubDate>Tue, 12 Apr 2011 20:59:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71235</guid>
		<description><![CDATA[BioScrip Inc. (BIOS), a health care-related company recently received accreditation for its specialty pharmacy and mail service pharmacy from Utilization Review Accreditation Commission (URAC), a Washington-based health care accrediting organization that establishes quality standards for the health care industry. URAC reached its decision after conducting a detailed review considering 146 parameters on BioScrip’s customer service and clinical pharmacy processes. Ensuring BioScrip’s positive approach towards healthcare needs, this award is expected to improve the company’s position in the specialty pharmacy industry. BioScrip’s specialty pharmacy and mail service pharmacy provide condition-specific clinical management, distribution and reimbursement programs of oral, injectable, and IV drug products for individuals suffering from chronic conditions. BioScrip, in partnership with healthcare payers, pharmaceutical manufacturers, government agencies and physicians strive to deliver cost effective programs to patients. Presently with ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/12/bios-bioscrip-pharmacy-accredited/71235/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2011/03/25/hgr-hanger-orthopedic-group-bull-of-the-day/69649</link>
		<comments>http://www.stockbloghub.com/2011/03/25/hgr-hanger-orthopedic-group-bull-of-the-day/69649#comments</comments>
		<pubDate>Fri, 25 Mar 2011 16:13:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=69649</guid>
		<description><![CDATA[We upgrade our recommendation on Hanger Orthopedic Group (HGR) to Outperform based on our assessment of the company&#8217;s forecast-beating fourth-quarter fiscal 2010 results and increased visibility on its business prospects. Earnings for the quarter topped the Zacks Consensus Estimate. Healthy contributions from the company&#8217;s patient-care and distribution businesses as well as acquisitions fueled double-digit growth in the top line. Hanger is the leader in the orthotic and prosthetic (O&#38;P) patient care services market and is enjoying healthy demand for its services. The company&#8217;s economies of scale are unmatched by its competitors. Hanger continues to pursue acquisitions to expand its geographic presence and revenues. Moreover, the company is poised to achieve meaningful cost synergies from its corporate relocation. HANGER ORTHOPED (HGR): Free Stock Analysis Report Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/25/hgr-hanger-orthopedic-group-bull-of-the-day/69649/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) BioScrip Analyst Reaffirms Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2010/12/27/bios-bioscrip-analyst-reaffirms-shares-at-neutral/63531</link>
		<comments>http://www.stockbloghub.com/2010/12/27/bios-bioscrip-analyst-reaffirms-shares-at-neutral/63531#comments</comments>
		<pubDate>Tue, 28 Dec 2010 00:01:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[AmerisourceBergen Corporation]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=63531</guid>
		<description><![CDATA[We maintain our Neutral recommendation on BioScrip Inc. (BIOS) following its tepid third-quarter fiscal 2010 results. Earnings for the quarter trailed both the Zacks Consensus Estimate and the year-ago earnings. Profit plummeted 66% year over year, hit by higher costs and tax. On a positive note, revenues grew at a healthy double-digit rate, driven by the synergies from the acquisition of Critical Homecare Solutions (“CHS”), a leading provider of infusion therapy products and services. However, organic (excluding the impact of acquisitions) revenue growth was disappointing. BioScrip witnessed softer patient reorder patterns and pricing pressure in some parts of its business, impacting the gross margin for the quarter. Consequent to the disappointing performance in the quarter, the company withdrew its full-year fiscal 2010 guidance and decided to review its business and ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/27/bios-bioscrip-analyst-reaffirms-shares-at-neutral/63531/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Quarterly Earnings Beats &#8211; Profit Slides</title>
		<link>http://www.stockbloghub.com/2010/11/03/hgr-hanger-orthopedic-quarterly-earnings-beats-profit-slides/57042</link>
		<comments>http://www.stockbloghub.com/2010/11/03/hgr-hanger-orthopedic-quarterly-earnings-beats-profit-slides/57042#comments</comments>
		<pubDate>Wed, 03 Nov 2010 15:29:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=57042</guid>
		<description><![CDATA[Hanger Orthopedic (HGR) posted adjusted earnings per share of 37 cents for third quarter fiscal 2010, beating the Zacks Consensus Estimate of 35 cents and exceeding the year-ago earnings of 30 cents. The adjusted earnings exclude costs (of $8 million) associated with the relocation of the company’s corporate headquarters and charges (of $0.6 million) related to the recently announced acquisition of Nevada-based rehabilitation technologies provider Accelerated Care Plus (&#8220;ACP&#8221;). Net income slid 28% year-over-year to $6.9 million (or 21 cents a share) largely on account of the hefty relocation costs. Revenues &#38; Margins Net sales rose 7.5% year-over-year to $206.7 million, modestly trailing the Zacks Consensus Estimate of $207 million. Sales improved on the back of higher revenues from same-center at patient-care segment (up 4.1%), company’s distribution segments (up 10.5%) ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/03/hgr-hanger-orthopedic-quarterly-earnings-beats-profit-slides/57042/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Prices $775 Million in Senior Notes</title>
		<link>http://www.stockbloghub.com/2010/10/08/dva-davita-prices-775-million-in-senior-notes/54536</link>
		<comments>http://www.stockbloghub.com/2010/10/08/dva-davita-prices-775-million-in-senior-notes/54536#comments</comments>
		<pubDate>Fri, 08 Oct 2010 16:33:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Barclays plc]]></category>
		<category><![CDATA[BCS]]></category>
		<category><![CDATA[Credit Suisse Group]]></category>
		<category><![CDATA[CS]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Liberty All Star Equity Fund]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=54536</guid>
		<description><![CDATA[Moving ahead with its debt restructuring activity, on Tuesday, DaVita Inc. (DVA) announced the pricing of $775 million principal amount of 6?% senior notes due 2018 and $775 million principal amount of 6?% senior notes due 2020 totaling $1.55 billion. The net proceeds from the offering will be used to redeem another set of outstanding 6?% senior notes due 2013 and 7¼% senior subordinated notes due 2015. DaVita has appointed Banc of America Securities LLC, an arm of Bank of America Corp. (BAC), J.P. Morgan Securities LLC of JP Morgan Chase &#38; Co. (JPM), Credit Suisse Securities (USA) LLC of Credit Suisse Group (CS), Barclays Capital Inc. of Barclays plc (BCS), Goldman, Sachs &#38; Co. of Goldman Sachs Group Inc. (GS) and Wells Fargo Securities LLC of Wells Fargo &#38; ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/08/dva-davita-prices-775-million-in-senior-notes/54536/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Plans $1.45 Billion Senior Notes</title>
		<link>http://www.stockbloghub.com/2010/10/05/dva-davita-plans-1-45-billion-senior-notes/54004</link>
		<comments>http://www.stockbloghub.com/2010/10/05/dva-davita-plans-1-45-billion-senior-notes/54004#comments</comments>
		<pubDate>Tue, 05 Oct 2010 15:32:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Barclays plc]]></category>
		<category><![CDATA[BCS]]></category>
		<category><![CDATA[Credit Suisse Group]]></category>
		<category><![CDATA[CS]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Liberty All Star Equity Fund]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=54004</guid>
		<description><![CDATA[Moving ahead with its debt restructuring activity, on Friday DaVita Inc. (DVA) announced its plan to sell about $1.45 billion of its senior notes and utilize the net proceeds to redeem another set of outstanding senior security notes, whose principal amount is worth $1.55 billion. The Board of DaVita had authorized a $3.35 billion debt refinancing activity in September 2010. The $1.55 billion notes includes 6.625% senior notes worth $700 million to be matured in 2013 and another set of 7.25% senior notes worth $850 million slated to mature in 2015. Recently, DaVita also affirmed that it has taken up credit line borrowings in order to refinance debt worth $1.8 billion under its existing senior secured credit facilities. However,  the terms of the $1.45 billion notes offering are yet to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/05/dva-davita-plans-1-45-billion-senior-notes/54004/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2010/08/04/hgr-hanger-orthopedic-bull-of-the-day/46604</link>
		<comments>http://www.stockbloghub.com/2010/08/04/hgr-hanger-orthopedic-bull-of-the-day/46604#comments</comments>
		<pubDate>Wed, 04 Aug 2010 14:04:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=46604</guid>
		<description><![CDATA[We reiterate our Outperform recommendation on Hanger Orthopedic (HGR). Earnings for the last quarter beat the Zacks Consensus Estimate by a penny. Top-line growth was fueled by healthy contributions from patient-care and distribution businesses and acquisitions. Hanger is the market leader in the orthotic and prosthetic (O&#38;P) patient care services market, operating through 678 patient care centers across the U.S. The company&#8217;s economies of scale are unmatched by its competitors. Hanger continues to pursue acquisitions to expand its geographic presence and revenues. While costs associated with relocation are expected to dilute earnings in the third quarter, the company is poised to achieve meaningful cost synergies from such initiatives in future reporting periods. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/04/hgr-hanger-orthopedic-bull-of-the-day/46604/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FMS) Fresenius Medical Care Buys Asia Renal Care</title>
		<link>http://www.stockbloghub.com/2010/05/25/fms-fresenius-medical-care-buys-asia-renal-care/38386</link>
		<comments>http://www.stockbloghub.com/2010/05/25/fms-fresenius-medical-care-buys-asia-renal-care/38386#comments</comments>
		<pubDate>Tue, 25 May 2010 23:08:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[FMS]]></category>
		<category><![CDATA[FRESENIUS MED ADS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=38386</guid>
		<description><![CDATA[Fresenius Medical Care (FMS) recently undertook a major expansion in dialysis services in the Asia-Pacific region by signing a sales and purchase agreement to acquire Asia Renal Care, a wholly owned subsidiary of Bumrungrad International, an associate company of Bumrungrad Hospital. If approved by the regulatory authorities in Taiwan and Singapore, the deal will add about $80 million to Fresenius Medical’s annual revenues. The transaction is expected to be accretive to earnings in the first year of operations. The markets for dialysis care in the Asia-Pacific region are expected to experience strong growth in the next five years with the number of patients slated to increase to more than 1 million from the current 680,000. Fresenius Medical is the dominant player followed by Asia Renal Care, which operates more than ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/25/fms-fresenius-medical-care-buys-asia-renal-care/38386/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Analyst Maintains Outperform</title>
		<link>http://www.stockbloghub.com/2010/05/24/hgr-hanger-orthopedic-group-analyst-maintains-outperform/38151</link>
		<comments>http://www.stockbloghub.com/2010/05/24/hgr-hanger-orthopedic-group-analyst-maintains-outperform/38151#comments</comments>
		<pubDate>Mon, 24 May 2010 20:51:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=38151</guid>
		<description><![CDATA[We reiterate our ‘Outperform’ rating on Hanger Orthopedic Group, Inc. (HGR) with a target price of $21 based on a P/E of 16.4x our fiscal 2010 EPS estimate of $1.28. The company’s results for the first quarter fiscal 2010 were outstanding with growth witnessed across all parameters. Hanger reported first quarter fiscal 2010 earnings per share of 16 cents, in line with the Zacks Consensus Estimate and higher than the year-ago earnings of 14 cents. Net sales for the first quarter increased 5.4% year-over-year to $178.3 million. Growth can be primarily attributed to higher same-center sales at patient care centers, higher demand for the company’s distribution segment and acquisitions. Patient-care services and distribution segments contributed 87.5% and 12.2% to total sales, respectively. In terms of payor mix: Commercial and other, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/24/hgr-hanger-orthopedic-group-analyst-maintains-outperform/38151/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Reports Earnings In Line With Expectations</title>
		<link>http://www.stockbloghub.com/2010/04/29/hgr-hanger-orthopedic-group-reports-earnings-in-line-with-expectations/35453</link>
		<comments>http://www.stockbloghub.com/2010/04/29/hgr-hanger-orthopedic-group-reports-earnings-in-line-with-expectations/35453#comments</comments>
		<pubDate>Thu, 29 Apr 2010 14:15:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=35453</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) reported first quarter fiscal 2010 earnings per share of 16 cents, in line with the Zacks Consensus Estimate and higher than the year-ago earnings of 14 cents. Sales Net sales for the first quarter increased 5.4% year over year to $178.3 million. Growth can be primarily attributed to higher same-center sales at patient care centers, higher demand for the company’s distribution segment and acquisitions. Patient-care services and distribution segments contributed 87.5% and 12.2% to total sales, respectively. In terms of payor mix: Commercial and other, Medicare, Medicaid and VA contributed 59.4%, 28.3%, 6.8% and 5.5% to total revenues, respectively. Margins Hanger witnessed an expansion in margins in the first quarter. Gross margin increased 10 basis points (bps) year over year to 69.9%. Excluding the office ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/29/hgr-hanger-orthopedic-group-reports-earnings-in-line-with-expectations/35453/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group &#8211; Consensus Earnings Estimates Rise</title>
		<link>http://www.stockbloghub.com/2010/03/30/hgr-hanger-orthopedic-group-consensus-earnings-estimates-rise/32306</link>
		<comments>http://www.stockbloghub.com/2010/03/30/hgr-hanger-orthopedic-group-consensus-earnings-estimates-rise/32306#comments</comments>
		<pubDate>Tue, 30 Mar 2010 17:08:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32306</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) saw revenue rise year over year in 2009 and projects further growth in 2010. Hanger is trading with a forward P/E of 14.7. Company Description Hanger Orthopedic Group operates 677 patient care centers specializing in orthotics and prosthetics as well as distribution centers in 45 states and the District of Columbia. The company also operates two other business units, Linkia, which provides network management for the orthotics and prosthetics industry, and Innovative Neurotronics, which provides independent research in neuromuscular technologies. Hanger Orthopedic Beat for the Third Straight Quarter On Feb 10, Hanger Orthopedic reported fourth quarter results which surprised on the Zacks Consensus by 2.8%. Earnings per share jumped 42.3% to 37 cents from 26 cents in the year ago period. The Zacks Consensus was ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/30/hgr-hanger-orthopedic-group-consensus-earnings-estimates-rise/32306/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Shows Positive Earnings Surprises and Earnings Revisions</title>
		<link>http://www.stockbloghub.com/2010/03/12/dva-davita-shows-positive-earnings-surprises-and-earnings-revisions/30481</link>
		<comments>http://www.stockbloghub.com/2010/03/12/dva-davita-shows-positive-earnings-surprises-and-earnings-revisions/30481#comments</comments>
		<pubDate>Fri, 12 Mar 2010 18:55:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30481</guid>
		<description><![CDATA[Last month, DaVita Inc. (DVA), a leading provider of dialysis services in the United States to patients suffering from chronic kidney failure (also known as end stage renal disease (ESRD), announced its financial results for the fourth quarter and fiscal year ended Dec 31, 2009. Earnings estimates for 2010 are on the rise following the release of strong fourth quarter and full year 2009 results. The company earned $1.06 per share, which was well above the year-ago earnings of 94 cents. For full year 2009, DaVita earned $4.06 per share, in line with the Zacks Consensus Estimate but higher than the year-ago earnings of $3.53. Profits increased 12% from the year-ago quarter on higher revenues. Net operating revenue for fiscal 2009 climbed approximately 8% to $6.11 billion. As of Dec ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/12/dva-davita-shows-positive-earnings-surprises-and-earnings-revisions/30481/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) BioScrip&#8217;s Fourth Quarter Report Shows Revenue Slide</title>
		<link>http://www.stockbloghub.com/2010/03/04/bios-bioscrips-fourth-quarter-report-shows-revenue-slide/29727</link>
		<comments>http://www.stockbloghub.com/2010/03/04/bios-bioscrips-fourth-quarter-report-shows-revenue-slide/29727#comments</comments>
		<pubDate>Thu, 04 Mar 2010 16:28:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29727</guid>
		<description><![CDATA[BioScrip Inc. (BIOS) reported fourth-quarter earnings of 99 cents per share Incorporatedluding the impact of items such as the reversal of deferred tax valuation allowance of $41.1 million, expenses of $1.8 million associated with the pending acquisition of Critical Homecare Solutions Inc. and $4.3 million of incentive compensation expense relating to the employee compensation program. Excluding one-time items and including stock-based compensation expense, BioScrip reported fourth quarter earnings of 2 cents, well below the Zacks Consensus Estimate of 10 cents. The company reported earnings of 8 cents in the year-ago period. Revenues for the quarter declined 6.8% to $341.6 million. Full year 2009 earnings came in at 39 cents, well above the year ago earnings of 22 cents. However, full year revenues declined 5.2% to $1.3 billion. While the specialty ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/04/bios-bioscrips-fourth-quarter-report-shows-revenue-slide/29727/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Beats Consensus Estimates</title>
		<link>http://www.stockbloghub.com/2010/02/17/hgr-hanger-orthopedic-group-beats-consensus-estimates/28243</link>
		<comments>http://www.stockbloghub.com/2010/02/17/hgr-hanger-orthopedic-group-beats-consensus-estimates/28243#comments</comments>
		<pubDate>Wed, 17 Feb 2010 22:48:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=28243</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) reported fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share were 37 cents, beating the Zacks Consensus Estimate of 36 cents and the year-ago earnings of 26 cents. For fiscal 2009, earnings per share were $1.13, higher than the year-ago earnings of 86 cents. Quarterly results Net sales for the fourth quarter increased 10.6% year over year to $205.1 million. Growth can be primarily attributed to higher same-center sales of patient care centers, higher demand for the company’s distribution segment and acquisitions. Hanger witnessed an expansion in margins in the fourth quarter. Gross margin increased 60 basis points (bps) year over year to 71.0%. Operating margin increased 160 bps year over year to 13.4%. Fiscal year results Total revenues in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/17/hgr-hanger-orthopedic-group-beats-consensus-estimates/28243/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ALLI) Allion Healthcare Beats Estimates by a Penny</title>
		<link>http://www.stockbloghub.com/2009/12/04/alli-allion-healthcare-beats-estimates-by-a-penny/22054</link>
		<comments>http://www.stockbloghub.com/2009/12/04/alli-allion-healthcare-beats-estimates-by-a-penny/22054#comments</comments>
		<pubDate>Sat, 05 Dec 2009 01:26:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ALLI]]></category>
		<category><![CDATA[Allion Healthcare]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22054</guid>
		<description><![CDATA[Allion Healthcare (ALLI) reported third quarter earnings of 13 cents per share excluding expenses related to the merger with an affiliate of H.I.G. Capital, LLC, beating the Zacks Consensus Estimate by a penny. The company reported identical earnings in the year-ago quarter. Revenues for the quarter came in at $103.4 million as against $92.1 million in the year-ago period, up 12.2%. Segment-wise, the specialty HIV division, through which Allion provides specialty pharmacy and disease management services focused on HIV/AIDS patients, recorded revenues of $78.4 million opposed to $ 70.3 million in the third quarter of 2008, up 11.5%. The increase in revenues in this segment is primarily attributable to an 8.2% increase in prescription volume and, to a lesser extent, an increase in the price of the anti-retroviral drugs sold ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/04/alli-allion-healthcare-beats-estimates-by-a-penny/22054/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HLS) HealthSouth Corporation &#8211; Raises Earnings Guidance</title>
		<link>http://www.stockbloghub.com/2009/11/07/hls-healthsouth-corporation-raises-earnings-guidance/19837</link>
		<comments>http://www.stockbloghub.com/2009/11/07/hls-healthsouth-corporation-raises-earnings-guidance/19837#comments</comments>
		<pubDate>Sun, 08 Nov 2009 00:53:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[HEALTHSOUTH Corporation]]></category>
		<category><![CDATA[HLS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19837</guid>
		<description><![CDATA[HealthSouth Corp. (HLS) is producing strong results by growing its revenue and more effectively managing its costs. Company Description HealthSouth Corp. operates as an inpatient care provider in the United States, owning and operating inpatient rehab care centers and long-term acute care hospitals. The company was founded in 1983 and has a market cap of $1.49 billion. Shares of HLS recently spiked higher after the company reported better than expected third-quarter results on Nov 3. Third-Quarter Results Revenue was up 4% from last year to $472.7 million. Earnings also came in strong at 38 cents per share, 14 cents ahead of the Zacks Consensus Estimate. HealthSouth has beat in each of the last four quarters by an average of 13 cents, or 74%. The company noted that its earnings growth ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/07/hls-healthsouth-corporation-raises-earnings-guidance/19837/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Tops Consensus Estimates</title>
		<link>http://www.stockbloghub.com/2009/11/04/dva-davita-tops-consensus-estimates/19660</link>
		<comments>http://www.stockbloghub.com/2009/11/04/dva-davita-tops-consensus-estimates/19660#comments</comments>
		<pubDate>Thu, 05 Nov 2009 00:17:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19660</guid>
		<description><![CDATA[DaVita Inc. (DVA) reported third quarter net income of $110.9 million or $1.06 per share, which was better than the Zacks Consensus Estimate of 99 cents. The company earned $93.9 million or 89 cents in the comparable quarter of 2008. Revenues for the quarter came in at $1.57 billion, which reflected an 8.3% increase over the year-ago quarter. According to segments, revenues from the Dialysis and Related Lab Services segment for the quarter came in at $1.49 billion as against $1.38 billion in the prior-year quarter. Other &#8211; Ancillary Services and Strategic Initiatives segment generated revenues of $83 million as against $69 million in the year-ago quarter. Highlights of the strong display in the reported quarter included consistent volume growth, stable private pricing and strong cash flows. Total treatments for ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/04/dva-davita-tops-consensus-estimates/19660/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) BioScrip Earnings Report Beats Forecasts in Q3</title>
		<link>http://www.stockbloghub.com/2009/11/02/bios-bioscrip-earnings-report-beats-forecasts-in-q3/19422</link>
		<comments>http://www.stockbloghub.com/2009/11/02/bios-bioscrip-earnings-report-beats-forecasts-in-q3/19422#comments</comments>
		<pubDate>Mon, 02 Nov 2009 21:28:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19422</guid>
		<description><![CDATA[BioScrip, Inc. (BIOS) reported third-quarter earnings of 14 cents per share, beating the Zacks Consensus Estimate of 10 cents. The company reported earnings of 6 cents in the year-ago period. Although earnings were better than expected, revenues declined 7.2% to $333.5 million. While the specialty business contributed $279 million to revenues, the pharmacy benefit management [PBM] business posted revenues of $54.5 million. The decline in revenues was mainly due to the elimination of the Medicare Competitive Acquisition Program and the termination of the United Health Group organ transplant and HIV/AIDS contracts. This was partially offset by increased sales of higher margin infusion therapies and other specialty sales. The company reported a sequential growth of 3% in specialty sales with several therapeutic areas like iron overload, multiple sclerosis [MS], oncology and ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/02/bios-bioscrip-earnings-report-beats-forecasts-in-q3/19422/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Beats Earnings Consensus</title>
		<link>http://www.stockbloghub.com/2009/10/27/hgr-hanger-orthopedic-group-beats-earnings-consensus/18953</link>
		<comments>http://www.stockbloghub.com/2009/10/27/hgr-hanger-orthopedic-group-beats-earnings-consensus/18953#comments</comments>
		<pubDate>Wed, 28 Oct 2009 01:23:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18953</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) yesterday reported financial results for the third quarter of fiscal 2009 after market close. Earnings per share were 30 cents, beating the Zacks Consensus Estimate of 27 cents and the year-ago earnings of 23 cents. Sales Net sales for the quarter increased 7.6% year over year to $192.3 million. Growth can be primarily attributed to higher same-center sales of patient care centers, higher demand for the company’s distribution segment and acquisitions. Patient-care services contributed approximately 88% to total sales while the remaining came from the distribution segment. Margins Gross margin declined 70 basis points (bps) year over year to 69.4% in the reported quarter due to higher cost of raw materials. However, strong sales and the company’s expense management initiatives helped it to increase operating ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/27/hgr-hanger-orthopedic-group-beats-earnings-consensus/18953/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ALLI) Allion Healthcare to be Acquired by H.I.G. Capital</title>
		<link>http://www.stockbloghub.com/2009/10/19/alli-allion-healthcare-to-be-acquired-by-h-i-g-capital/18109</link>
		<comments>http://www.stockbloghub.com/2009/10/19/alli-allion-healthcare-to-be-acquired-by-h-i-g-capital/18109#comments</comments>
		<pubDate>Mon, 19 Oct 2009 16:42:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ALLI]]></category>
		<category><![CDATA[Allion Healthcare]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18109</guid>
		<description><![CDATA[Recently, Allion Healthcare Inc. (ALLI) inked a deal with an affiliate of H.I.G. Capital, LLC, a leading global private investment firm, whereby it agreed to be acquired by the private company. The deal is worth approximately $278 million. The amount is inclusive of the assumption or repayment of about $79 million of indebtedness. The transaction is expected to close in the first quarter of 2010. Under the terms of the transaction, Allion shareholders would receive $6.60 per share in cash. This represents a premium of 30.2% over Allion&#8217;s five-day average closing price before the announcement of the deal. Consequently, this transaction provides substantial financial gains to Allion shareholders. The transaction has been approved by Allion’s Board of Directors. Additionally, other shareholders of Allion Incorporatedluding Parallex LLC, who in aggregate hold ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/19/alli-allion-healthcare-to-be-acquired-by-h-i-g-capital/18109/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group on Acquisition Spree</title>
		<link>http://www.stockbloghub.com/2009/10/12/hgr-hanger-orthopedic-group-on-acquisition-spree/17391</link>
		<comments>http://www.stockbloghub.com/2009/10/12/hgr-hanger-orthopedic-group-on-acquisition-spree/17391#comments</comments>
		<pubDate>Mon, 12 Oct 2009 17:04:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17391</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) recently made three acquisitions totaling $10.7 million in annual net revenues. These acquisitions are: Creative Orthotics &#38; Prosthetics, Inc.; Custom Orthopedics of Wyoming; and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania. These acquisitions will enable Hanger to add patient care centers to its existing markets in New York, Wyoming and Pennsylvania. Hanger will fund these acquisitions from internally generated cash flows. It is estimated that the acquisitions will be accretive to Hanger’s earnings once the integration process is over. The acquisitions strengthen Hanger’s leadership position in the orthotic and prosthetic (O&#38;P) market and bolster its top-line. Hanger Orthopedic Group, based in Bethesda, MD, provides orthotic and prosthetic patient care services through its 671 patient care centers in the U.S. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/12/hgr-hanger-orthopedic-group-on-acquisition-spree/17391/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Inc. Trade With a PEG of 0.90</title>
		<link>http://www.stockbloghub.com/2009/08/27/hgr-hanger-orthopedic-group-inc-trade-with-a-peg-of-0-90/13581</link>
		<comments>http://www.stockbloghub.com/2009/08/27/hgr-hanger-orthopedic-group-inc-trade-with-a-peg-of-0-90/13581#comments</comments>
		<pubDate>Thu, 27 Aug 2009 19:46:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=13581</guid>
		<description><![CDATA[Hanger Orthopedic Group Inc. (HGR) is expected to grow earnings at 15% over the next five years. The company saw revenues rise 6.8% year over year in the second quarter in a tough economic environment. HGR doesn&#8217;t just have growth, it also has value. The company trades with a PEG ratio of 0.90. Company Description Hanger Orthopedic Group operates 671 patient care centers specializing in orthotics and prosthetics as well as distribution centers in 45 states and the District of Columbia. The company also operates two other business units, Linkia, which provides network management for the orthotics and prosthetics industry, and Innovative Neurotronics, which provides independent research in neuromuscular technologies. Revenues Jumped 6.8% Year Over Year On July 28, Hanger Orthopedic Group surprised on the second quarter Zacks Consensus Estimate ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/27/hgr-hanger-orthopedic-group-inc-trade-with-a-peg-of-0-90/13581/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group, Inc. &#8211; 25% spike in net income</title>
		<link>http://www.stockbloghub.com/2009/08/07/hgr-hanger-orthopedic-group-inc-25-spike-in-net-income/12123</link>
		<comments>http://www.stockbloghub.com/2009/08/07/hgr-hanger-orthopedic-group-inc-25-spike-in-net-income/12123#comments</comments>
		<pubDate>Fri, 07 Aug 2009 21:09:42 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=12123</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) is seeing consistent year-over-year earnings growth and has just topped estimates on higher sales. Company Description Hanger Orthopedic Group Inc. develops, acquires and operates orthotic and prosthetic patient-care centers. The centers design, fabricate, fit and supervise the use of external musculoskeletal support devices and artificial limbs. The company also manufactures devices and is the country&#8217;s largest distributor of orthotics and prosthetics components. Beats Expectations On Jul 28 the company reported second-quarter results that included sales of almost $194 million, up 7% on a year-over-year basis. This led to a 25% spike in net income which rose to $10 million. Earnings per share came in at 31 cents, beating the Zacks consensus estimate by 4 cents. The company earned just 25 cents in the same period ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/07/hgr-hanger-orthopedic-group-inc-25-spike-in-net-income/12123/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HLS) Healthsouth Corp. &#8211; Momentum &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/07/07/hls-healthsouth-corp-momentum-zacks-rank-buy/9457</link>
		<comments>http://www.stockbloghub.com/2009/07/07/hls-healthsouth-corp-momentum-zacks-rank-buy/9457#comments</comments>
		<pubDate>Tue, 07 Jul 2009 23:13:26 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[HEALTHSOUTH Corp.]]></category>
		<category><![CDATA[HLS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=9457</guid>
		<description><![CDATA[Healthsouth Corp. (HLS) continues to rally on strong quarterly results and bullish earnings projections. Company Description HealthSouth Corp. provides inpatient rehabilitation services in the United States. The company own and operates more than 90 inpatient rehab hospitals, of which 65 it owns. HealthSouth was founded in 1983 and has a market cap of $1.2 billion. Shares of HLS have more than doubled in the last 3 months, helped by the company&#8217;s strong first-quarter results, reported on May 5. First-Quarter Results Sales were up 2% from last year to $475.1 million. Income was up big, jumping to $38.4 million from $13.3 million last year, producing earnings of 39 cents per share, 19 cents ahead of the consensus estimate. Estimates Climbing Analysts continue to be bullish on HealthSouth, with the current-year estimate ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/07/07/hls-healthsouth-corp-momentum-zacks-rank-buy/9457/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) Healthcare Industry &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2009/05/29/bios-healthcare-industry-industry-outlook/7598</link>
		<comments>http://www.stockbloghub.com/2009/05/29/bios-healthcare-industry-industry-outlook/7598#comments</comments>
		<pubDate>Sat, 30 May 2009 01:43:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[Community Health Systems Inc.]]></category>
		<category><![CDATA[CYH]]></category>
		<category><![CDATA[NOVA]]></category>
		<category><![CDATA[NovaMed Inc.]]></category>
		<category><![CDATA[UHS]]></category>
		<category><![CDATA[Universal Health Services Inc.]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=7598</guid>
		<description><![CDATA[Investor sentiment in healthcare continues to be driven by both Washington and the state of the broader economy. In late February, President Obama released his administration&#8217;s first budget proposal, which included the provision of a $630B reserve fund for healthcare reform over the next 10 years, financed in part by increases in taxes and changes to government program payments for physicians, hospitals and insurers (Medicare Advantage in particular). Details of the measure continue to evolve as discussions continue at the congressional level. Earlier in February, the $787B economic stimulus package was passed in the Senate and House. The $150B in planned healthcare spending will include $25B towards the expansion of COBRA, $20B for health technology, and $85B for Medicaid assistance to states. The package clearly aims to improve the infrastructure ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/05/29/bios-healthcare-industry-industry-outlook/7598/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PRSC) Providence Service Corp. &#8211; Momentum &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/04/22/prsc-providence-service-corp-momentum-zacks-rank-buy/5884</link>
		<comments>http://www.stockbloghub.com/2009/04/22/prsc-providence-service-corp-momentum-zacks-rank-buy/5884#comments</comments>
		<pubDate>Wed, 22 Apr 2009 22:48:42 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Providence Service Corp.]]></category>
		<category><![CDATA[PRSC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=5884</guid>
		<description><![CDATA[Providence Service Corp.&#8217;s (PRSC) share price has been on a serious rally for the last 4 weeks, climbing from just over $2 in early March to a recent high just shy of $10. Rising estimates and impressive quarterly results have fueled the big gain. Company Description The Providence Services Corp. provides and manages government sponsored social services to individuals and families in the United States. The company was founded in 1996 and has a market cap of $115 million. Fourth-Quarter Results Shares of PRSC received a nice boost from the company&#8217;s solid fourth-quarter results, reported on Mar 13. Revenue was up 80% from last year to $178 million. When excluding certain one-time items, earnings came in at 55 cents per share, blowing past the consensus estimate of 6 cents. Estimates ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/04/22/prsc-providence-service-corp-momentum-zacks-rank-buy/5884/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ALLI) Allion Healthcare Inc. &#8211; Aggressive Growth &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/04/22/alli-allion-healthcare-inc-aggressive-growth-zacks-rank-buy/5882</link>
		<comments>http://www.stockbloghub.com/2009/04/22/alli-allion-healthcare-inc-aggressive-growth-zacks-rank-buy/5882#comments</comments>
		<pubDate>Wed, 22 Apr 2009 22:37:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ALLI]]></category>
		<category><![CDATA[Allion Healthcare Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=5882</guid>
		<description><![CDATA[Allion Healthcare, Inc. (ALLI) has been growing steadily since its acquisition of Biomed was finalized one year ago. Company Description Allion Healthcare, Inc. is a national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients. Allion Healthcare sells HIV/AIDS medications, ancillary drugs and nutritional supplies under the trade name MOMS Pharmacy. Sales Up 52% On Mar 4 Allion announced fourth-quarter results that included sales of $96.9 million, up 52% from $63.6 million. Strong sales drove net income up to $3.1 million, almost triple last year&#8217;s $1.1 million. Earnings per share doubled to 12 cents, which met analysts&#8217; expectations. Before meeting the consensus Allion beat the Street 3 consecutive quarters. Successful Acquisition Much of the recent success of the company has been due to the acquisition of Biomed, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/04/22/alli-allion-healthcare-inc-aggressive-growth-zacks-rank-buy/5882/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PRSC) Top Performer for Monday: Providence Service- Zacks #1 Rank Top Performers</title>
		<link>http://www.stockbloghub.com/2009/04/20/prsc-top-performer-for-monday-providence-service-zacks-1-rank-top-performers/5756</link>
		<comments>http://www.stockbloghub.com/2009/04/20/prsc-top-performer-for-monday-providence-service-zacks-1-rank-top-performers/5756#comments</comments>
		<pubDate>Mon, 20 Apr 2009 20:07:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Providence Service Corp.]]></category>
		<category><![CDATA[PRSC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=5756</guid>
		<description><![CDATA[The Providence Service Corporation (PRSC) raised its first-quarter earnings per share guidance to 35 cents, which puts it 10 cents ahead of the consensus of 25 cents. Furthermore, the company now sees revenue between $180 million and $185 million. In late March, the company was expecting EPS of 25 cents on revenue of $170 million to $180 million. Shares are up more than 8% so far on Monday during what looks to be a difficult session for the market. This makes PRSC one of the top-performing Zacks #1 Rank companies for the day. Volume is around 164,000, compared to the average of about 100,000. PRSC made the announcement a day before its CEO presents an overview of operations at the CIT 4th Annual Healthcare Conference. Earnings per share for the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/04/20/prsc-top-performer-for-monday-providence-service-zacks-1-rank-top-performers/5756/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ASGR) America Service Group, Inc. &#8211; Momentum &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/03/12/asgr-america-service-group-inc-momentum-zacks-rank-buy/4211</link>
		<comments>http://www.stockbloghub.com/2009/03/12/asgr-america-service-group-inc-momentum-zacks-rank-buy/4211#comments</comments>
		<pubDate>Thu, 12 Mar 2009 22:58:17 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[America Service Group Inc.]]></category>
		<category><![CDATA[ASGR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=4211</guid>
		<description><![CDATA[America Service Group, Inc. (ASGR) just reported solid fourth-quarter and full-year results and looks well positioned for a year of impressive earnings growth. Company Description America Service Group, Inc., through its subsidiaries, provides managed healthcare services to correctional facilities in the United States. The company was founded in 1978 and has a market cap of $108 million. Fourth-Quarter Results America Services Group reported strong fourth-quarter and full-year results on March 3 that were ahead of analyst estimates and a big improvement from last year. Revenue from continuing contracts increased 4.9% to $120.8 million. Income came in at $1.2 million, up from a loss of $685,000 last year. Earnings totaled 15 cents per share, one penny ahead of the consensus estimate. Full-Year Results Full-year revenue from continuing contracts were up 7.3% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/03/12/asgr-america-service-group-inc-momentum-zacks-rank-buy/4211/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(IPCM) IPC The Hospitalist Company &#8211; analysts are bullish about 2009, however, expecting earnings growth of 28.02%</title>
		<link>http://www.stockbloghub.com/2009/01/22/ipcm-ipc-the-hospitalist-company-analysts-are-bullish-about-2009-however-expecting-earnings-growth-of-2802/2295</link>
		<comments>http://www.stockbloghub.com/2009/01/22/ipcm-ipc-the-hospitalist-company-analysts-are-bullish-about-2009-however-expecting-earnings-growth-of-2802/2295#comments</comments>
		<pubDate>Thu, 22 Jan 2009 19:51:07 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[IPC The Hospitalist Company]]></category>
		<category><![CDATA[IPCM]]></category>
		<category><![CDATA[VitalStocks]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=2295</guid>
		<description><![CDATA[IPC The Hospitalist Company, Inc. (IPCM) saw record third quarter results in November as revenue climbed 32% on the strength of the company&#8217;s acquisition strategy. IPCM has a PEG of only 0.6. Company Description IPC operates and manages hospitalist physician group practices throughout the United States. Hospitalists are acute-care physicians, nurse practitioners and physician assistants who focus on a patient&#8217;s hospital care from the time of admission to discharge and then have no contact with the patient after discharge. Hospitalists practice exclusively in hospitals and other inpatient facilities Incorporatedluding acute, sub-acute and long-term care facilities. The company continues with its strategy to acquire practice groups. In 2008, it acquired ten groups in same-markets and in new markets Incorporatedluding the acquisition of Hospitalists of America, which provided an entry into the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/01/22/ipcm-ipc-the-hospitalist-company-analysts-are-bullish-about-2009-however-expecting-earnings-growth-of-2802/2295/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HLS) HealthSouth &#8211; 15 cents for the third quarter, more than double the consensus of 7 cents</title>
		<link>http://www.stockbloghub.com/2009/01/20/hls-healthsouth-15-cents-for-the-third-quarter-more-than-double-the-consensus-of-7-cents/2229</link>
		<comments>http://www.stockbloghub.com/2009/01/20/hls-healthsouth-15-cents-for-the-third-quarter-more-than-double-the-consensus-of-7-cents/2229#comments</comments>
		<pubDate>Wed, 21 Jan 2009 00:43:49 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[HEALTHSOUTH Corp.]]></category>
		<category><![CDATA[HLS]]></category>
		<category><![CDATA[VitalStocks]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=2229</guid>
		<description><![CDATA[HealthSouth Corp (HLS) shares have been climbing recently while analysts are upping their earnings estimates for 2009. Company Description HealthSouth Corp. is the one of the nation&#8217;s largest providers of outpatient surgery and rehabilitative healthcare services. The company provides these services through its national network of inpatient and outpatient healthcare facilities Incorporatedluding inpatient and outpatient rehabilitation facilities, outpatient surgery centers, diagnostic centers, occupational medicine centers, medical centers and other healthcare facilities. Another Surprise On Nov 4th HealthSouth announced earnings per share of 15 cents for the third quarter, more than double the consensus of 7 cents. This was the companies third earnings surprise in the past 4 quarters, with the other announcement meeting expectations. Following the announcement analysts have revised full-year 2009 estimates, which now average 81 cents, up from ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/01/20/hls-healthsouth-15-cents-for-the-third-quarter-more-than-double-the-consensus-of-7-cents/2229/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group &#8211; announced 28% year-over-year earnings growth when it reported its third-quarter results</title>
		<link>http://www.stockbloghub.com/2009/01/02/hgr-hanger-orthopedic-group-announced-28-year-over-year-earnings-growth-when-it-reported-its-third-quarter-results/1933</link>
		<comments>http://www.stockbloghub.com/2009/01/02/hgr-hanger-orthopedic-group-announced-28-year-over-year-earnings-growth-when-it-reported-its-third-quarter-results/1933#comments</comments>
		<pubDate>Fri, 02 Jan 2009 23:57:34 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[VitalStocks]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=1933</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) recently reported 28% earnings growth and forecasts continue the trend. Shares continue trade at attractive valuations. Company Description Hanger Orthopedic Group Inc. develops, acquires and operates orthotic and prosthetic patient-care centers. The Orthotics &#38; Prosthetics centers are staffed by orthotists and prosthetists, who design, fabricate, fit and supervise the use of external musculoskeletal support devices and artificial limbs. The company also manufacture custom-made and prefabricated Orthotics &#38; Prosthetics devices and are the country&#8217;s largest distributor of Orthotics &#38; Prosthetics components and finished Orthotics &#38; Prosthetics patient-care products. Surprises Continue Despite Recession Hanger announced 28% year-over-year earnings growth when it reported its third-quarter results. Earnings per share were 23 cents, up from 19 cents on year ago. This was the company&#8217;s fourth consecutive EPS surprise, as ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/01/02/hgr-hanger-orthopedic-group-announced-28-year-over-year-earnings-growth-when-it-reported-its-third-quarter-results/1933/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(USPH) &#8211; U.S. Physical Therapy &#8211; operates 364 clinics in 41 states</title>
		<link>http://www.stockbloghub.com/2008/10/25/usph-us-physical-therapy-operates-364-clinics-in-41-states-3/1089</link>
		<comments>http://www.stockbloghub.com/2008/10/25/usph-us-physical-therapy-operates-364-clinics-in-41-states-3/1089#comments</comments>
		<pubDate>Sat, 25 Oct 2008 14:46:40 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[USPH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/0011089/2008/10/25/usph-us-physical-therapy-operates-364-clinics-in-41-states-3</guid>
		<description><![CDATA[U.S. Physical Therapy, Inc. (USPH) has acquired controlling stakes in 2 rehabilitation practices in the past 4 months. Earnings remain strong and are projecting growth rates around 19%.Company Description U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. As of August, the company operates 364 clinics in 41 states. US Physical has more that 1,600 employees, is head quartered in Houston, Texas, and has a market cap of $158 million. Acquired Stake in Rehab Management Group On Oct 8 U.S. Physical announced an acquisition of a 65% interest in Rehab Management Group. RMG focuses on nerve and muscle function with services including electro-diagnostic analysis, intra articular joint, and lumbar osteoarthritis programs. The majority ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/10/25/usph-us-physical-therapy-operates-364-clinics-in-41-states-3/1089/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(USPH) &#8211; U.S. Physical Therapy &#8211; operates 364 clinics in 41 states</title>
		<link>http://www.stockbloghub.com/2008/10/24/usph-us-physical-therapy-operates-364-clinics-in-41-states-2/1059</link>
		<comments>http://www.stockbloghub.com/2008/10/24/usph-us-physical-therapy-operates-364-clinics-in-41-states-2/1059#comments</comments>
		<pubDate>Fri, 24 Oct 2008 21:20:29 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[USPH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/0011059/2008/10/24/usph-us-physical-therapy-operates-364-clinics-in-41-states-2</guid>
		<description><![CDATA[U.S. Physical Therapy, Inc. (USPH) has acquired controlling stakes in 2 rehabilitation practices in the past 4 months. Earnings remain strong and are projecting growth rates around 19%.Company Description U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. As of August, the company operates 364 clinics in 41 states. US Physical has more that 1,600 employees, is head quartered in Houston, Texas, and has a market cap of $158 million. Acquired Stake in Rehab Management Group On Oct 8 U.S. Physical announced an acquisition of a 65% interest in Rehab Management Group. RMG focuses on nerve and muscle function with services including electro-diagnostic analysis, intra articular joint, and lumbar osteoarthritis programs. The majority ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/10/24/usph-us-physical-therapy-operates-364-clinics-in-41-states-2/1059/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(USPH) &#8211; U.S. Physical Therapy &#8211; operates 364 clinics in 41 states</title>
		<link>http://www.stockbloghub.com/2008/10/23/usph-us-physical-therapy-operates-364-clinics-in-41-states/1028</link>
		<comments>http://www.stockbloghub.com/2008/10/23/usph-us-physical-therapy-operates-364-clinics-in-41-states/1028#comments</comments>
		<pubDate>Fri, 24 Oct 2008 04:00:29 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[USPH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/0011028/2008/10/23/usph-us-physical-therapy-operates-364-clinics-in-41-states</guid>
		<description><![CDATA[U.S. Physical Therapy, Inc. (USPH) has acquired controlling stakes in 2 rehabilitation practices in the past 4 months. Earnings remain strong and are projecting growth rates around 19%.Company Description U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. As of August, the company operates 364 clinics in 41 states. US Physical has more that 1,600 employees, is head quartered in Houston, Texas, and has a market cap of $158 million. Acquired Stake in Rehab Management Group On Oct 8 U.S. Physical announced an acquisition of a 65% interest in Rehab Management Group. RMG focuses on nerve and muscle function with services including electro-diagnostic analysis, intra articular joint, and lumbar osteoarthritis programs. The majority ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/10/23/usph-us-physical-therapy-operates-364-clinics-in-41-states/1028/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) &#8211; Hanger Orthopedic Group &#8211; Net income jumped ahead 57.2% from last year</title>
		<link>http://www.stockbloghub.com/2008/08/20/hgr-hanger-orthopedic-group-net-income-jumped-ahead-572-from-last-year/340</link>
		<comments>http://www.stockbloghub.com/2008/08/20/hgr-hanger-orthopedic-group-net-income-jumped-ahead-572-from-last-year/340#comments</comments>
		<pubDate>Wed, 20 Aug 2008 15:20:05 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[HGR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001340/2008/08/20/hgr-hanger-orthopedic-group-net-income-jumped-ahead-572-from-last-year</guid>
		<description><![CDATA[Hanger Orthopedic Group Inc. (HGR) has been posting steady gains since its stock price bottomed out in late April. The company is fresh off the heels of a great second quarter, and analysts have been boosting their earnings estimates in anticipation of robust earnings.Hanger Orthopedic Group Inc. owns and operates orthotic and prosthetic patient-care centers in the United States. The company has a market cap. of $435 million and is headquartered in Bethesda, Maryland. A Great Quarter Shares of HGR have been on a nice rally over the last two weeks, assisted by the company&#8217;s excellent second-quarter results, reported on July 29. Sales were up 13% from the same period last year to $181.2 million. Net income jumped ahead 57.2% from last year to $8.0 million. This produced earnings of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/08/20/hgr-hanger-orthopedic-group-net-income-jumped-ahead-572-from-last-year/340/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

